Join expert faculty for a 1-hour, interactive multimedia program with downloadable slides and an interactive case study and patient video. Learn about new recommendations and clinical evidence on the safety and efficacy of direct-acting oral anticoagulants (DOACs) in patients with obesity.
This program is accompanied by 2 ClinicalThought commentaries by expert faculty on the topic of venous thromboembolism (VTE) management in patients with obesity, and a downloadable handout that can be shared with patients.
Faculty
Christian T. Ruff, MD, MPH Associate Professor of MedicineHarvard Medical SchoolDirectorGeneral CardiologyCardiovascular DivisionBrigham and Women's HospitalBoston, Massachusetts
Daniel Thibodeau, DHSc, MHP, PA-C Physician Assistant ProgramDirector of Medical Science ProgramEastern Virginia Medical SchoolPhysician AssistantDivision of CardiologySentara Medical GroupSentara Health SystemsNorfolk, Virginia
Managing VTE After Bariatric Surgery
- ClinicalThought
- Expiration Date: 5/22/23
- Not certified for credit.
Preventing Recurrent VTE in Persons with Obesity
- ClinicalThought
- Expiration Date: 5/08/23
- Not certified for credit.
Weighing in on Optimal Management of VTE in Patients With Obesity
- eCourse
- Expiration Date: 4/14/23
- Credit Hours: 1.00
- Pharmacology Credit Hours: 1.00
Weighing in on Optimal Management of VTE in Patients With Obesity
- PDF Resource
- Expiration Date: 4/14/23
- Not certified for credit.
Weighing in on Optimal Management of VTE in Patients With Obesity
- Downloadable Slideset
- Expiration Date: 4/14/23
- Not certified for credit.
Provided by Practicing Clinicians Exchange.
Supported by an educational grant from the Bristol-Myers Squibb and Pfizer Alliance; and Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.
